NCT07088289Not yet recruiting
VR Mindfulness for People With HIV and Substance Use
Virtual Reality Mindfulness Intervention for Supporting People With HIV and Substance Use
Source: ClinicalTrials.gov · Last updated 4 Nov 2026
Brief summary (registry, in English)
The goal of this clinical trial is to explore whether a virtual reality (VR) mindfulness app is acceptable, appropriate, and feasible for supporting people with HIV and substance use problems. Participants will: * Use a VR headset with a mindfulness app at home; * Complete three online surveys over three months; * Take part in an individual interview or focus group to share their experiences.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 19 Jul 2025
- Start date
- Dec 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- University of Texas at Austin
- Diseases
- HIV
- NCT number
- NCT07088289
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Dec 2026 to the primary completion date, Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Terminal illness with a life expectancy of less than 6 months
- Having visual or auditory impairments or severe physical disabilities that hinder VR use, history of seizures, severe cognitive impairment, severe motion sickness, severe unmanaged psychiatric symptoms, or currently pregnant
Other
- Living in institutionalized settings or unsheltered
- Planning to move out of the area in the next eight weeks
- Engaging in regular mindfulness practice outside of TRIPP
- Experiencing fear of closed spaces or unable to tolerate wearing a VR headset (verified during orientation session)
- Participants without home internet access will not be excluded and will be provided either funding for internet service or VR headsets preloaded with TRIPP sessions for offline use.
Who the study is looking for
- Able to speak, read, and write in English
- Aged 18 years or older
- Diagnosed with HIV
- Currently prescribed ART therapy
- Reporting moderate to high risk related to alcohol, opioids, nicotine, cannabis, or stimulant use (score of 4 or higher on the Alcohol, Smoking, and Substance Involvement Screening Test - ASSIST). Participants may also use other substances, but the primary risk must fall within these categories, as these have the strongest research support for mindfulness-based interventions.
- Having stable housing that allow using VR safely
- Willing to provide contact information for at least one person whom the study team can reach if the participant becomes unreachable after repeated attempts
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.